Biotech | April 22, 2025
Vgenomics and Meril Genomics collaborate to revolutionise precision medicine
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Biogen paid Ionis a US $ 60 million one-time upfront payment
The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households
The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit dramatically increase throughput for WGA by processing up to 1,500 cells per run
Presidential Symposium for NIAGARA will highlight practice-changing impact of a perioperative Imfinzi-based regimen in bladder cancer
Nor UDCA is likely to be a first-in-class treatment option for NAFLD in India
The new 10-year contract will focus on strengthening the partnership for continued transformative innovation for patients
The report underscores significant advancements in healthcare delivery, showcasing how GenAI facilitates improved diagnostic accuracy, operational efficiency and patient engagement
US FDA approval based on NEURO-TTRansform Phase III results
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Subscribe To Our Newsletter & Stay Updated
